|
Centrosome aberrations in bone marrow cells from patients with myelodysplastic syndromes correlate with chromosomal instability.
|
May 2013
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
|
Efficacy and safety of deferasirox in myelodysplastic syndromes
|
Feb 2013
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
|
Thrombotic complications without evidence of hemolysis in paroxysmal nocturnal hemoglobinuria: is eculizumab indicated?
|
Jul 2012
|
Ann Hematol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Biosimilar epoetin in elderly patients with low-risk myelodysplastic syndromes improves anemia, quality of life, and brain function
|
Apr 2014
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
|
Development of a disease-specific quality of life questionnaire for patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria (QLQ-AA/PNH)-report on phases I and II
|
Nov 2016
|
Ann Hematol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Azacitidine-lenalidomide (ViLen) combination yields a high response rate in higher risk myelodysplastic syndromes (MDS)-ViLen-01 protocol
|
Aug 2016
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
|
Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab
|
Jan 2017
|
Ann Hematol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Can iron overload in patients with lower-risk myelodysplastic syndromes be reduced using erythropoiesis-stimulating agents?
|
Oct 2015
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
|
Rabbit antithymocyte globulin versus horse antithymocyte globulin for treatment of acquired aplastic anemia: a retrospective analysis
|
Feb 2015
|
Ann Hematol
|
aplastic anemia
|
|
Asymptomatic cerebral bleeds in patients with aplastic anemia.
|
Mar 2012
|
Ann Hematol
|
aplastic anemia
|
